Comparison of Non-albuminuric and Microalbuminuric Diabetic Patients
DOI:
https://doi.org/10.3329/medtoday.v37i2.83209Keywords:
Social media and public health, Urban health governance, Vaccine hesitancy in LMICs, Public sector management, Digital health strategies, Health misinformation, Dhaka health infrastructure, Adaptive public health campaigns and Behavioural communication in pandemics.Abstract
Introduction with Objective: The aim of the present study was to compare the Non-albuminuric and microalbuminuric Diabetic Patients. Materials and Methods: This comparative study was conducted in the Department of Laboratory Medicine, BSMMU, Shahbagh, Dhaka. The duration of the study was from June 2022 to February 2023. Diagnosed patients with diabetes mellitus who fulfill the inclusion and exclusion criteria were selected as the study population. After data collection and processing, all statistical analysis was done by SPSS software windows version 26. Result: Majority of microalbuminuric subjects (n=17, 37%) were 60-69 years. Male patients were suffering from more microalbuminuria. Mean (±SD) BMI of non-albuminuric and microalbuminuric subjects were 23.76±4.18 kg/m2 and 23.90±3.50 kg/m2 respectively. Mean(±SD) disease duration was 6.63±1.37 years in non-albuminuric and 7.41±1.73 years in microalbuminuric subjects. The difference of disease duration was statistically significant between non-albuminuric & microalbuminuric subjects (p<0.018). Mean value of HbA1c was 6.92±1.77 in non-albuminuric and 7.27±1.58 in microalbuminuric study subjects which was statistically not significant. Mean serum creatinine level in non-albuminuric and microalbuminuric subjects were 1.33±0.33 and 1.45±0.37 respectively and e-GFR level in non-albuminuric and microalbuminuric subjects were 57.4±21.3 and 55.8±24.1 respectively. Serum creatinine and e-GFR level between the non-albuminuric and microalbuminuric study subjects were statistically significant. Conclusion: Prevalence of microalbuminuria showed statistically significant association with age, duration of diabetes, serum creatinine and e-GFR level.
Medicine Today 2025, Vol.37 (2): 164-166